These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6307604)

  • 1. Plasmid-independent resistance of 'gray' colony variants of a strain of Serratia marcescens resistant to amikacin, cefotaxime and lamoxactam.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1983; 29(4):265-74. PubMed ID: 6307604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific aminoglycoside cross-resistance of Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):204-13. PubMed ID: 378576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane protein alterations in Serratia marcescens resistant against aminoglycoside and beta-lactam antibiotics.
    Traub WH; Bauer D
    Chemotherapy; 1987; 33(3):172-6. PubMed ID: 3297527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance-plasmid- and protease-independent murine virulence of a multiple-drug-resistant strain of Serratia marcescens.
    Traub WH; Spohr M; Bauer D
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):184-95. PubMed ID: 6369833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
    Miller MA; LeFrock JL; Vercler MJ
    Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD; Pasiecznik K
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens.
    John JF; McNeill WF; Price KE; Kresel PA
    Antimicrob Agents Chemother; 1982 Apr; 21(4):587-91. PubMed ID: 7044303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens.
    Kurtz TO; Winston DJ; Bruckner DA; Martin WJ
    Antimicrob Agents Chemother; 1981 Aug; 20(2):239-43. PubMed ID: 6792982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
    Kawakami Y; Okimura Y; Horiuchi N; Kanai M
    Jpn J Antibiot; 1982 Sep; 35(9):2314-7. PubMed ID: 6292543
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromosomal origin of acetyltransferase AAC(6') specifying amikacin resistance in Serratia marcescens.
    Gómez-Lus R; Rivera MJ; Bobey D; Martín C; Navarro M
    Microbiologia; 1987 Oct; 3(3):185-94. PubMed ID: 3077328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.
    Markowitz SM; Sibilla DJ
    Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survey of modifying enzymes and plasmids in amikacin-resistant Serratia marcescens.
    Katoh-Kanno R; Kimura M; Ikeda T; Kimura S
    Microbiol Immunol; 1986; 30(6):509-19. PubMed ID: 3528769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-determined resistance to fosfomycin in Serratia marcescens.
    Mendoza C; Garcia JM; Llaneza J; Mendez FJ; Hardisson C; Ortiz JM
    Antimicrob Agents Chemother; 1980 Aug; 18(2):215-9. PubMed ID: 7004337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.
    Livingston WK; Elliott AM; Cobbs CG
    Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens.
    Goldstein FW; Gutmann L; Williamson R; Collatz E; Acar JF
    Ann Microbiol (Paris); 1983; 134A(3):329-37. PubMed ID: 6357025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a nosocomially significant, multiple drug-resistant strain of Serratia marcescens.
    Traub WH; Kleber I; Pühler A; Burkardt HJ
    Chemotherapy; 1976; 22(5):297-312. PubMed ID: 181215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical and functional map of an amikacin-resistance plasmid isolated from a multiresistant strain of Serratia marcescens.
    Kanno R
    Microbiol Immunol; 1988; 32(3):241-50. PubMed ID: 2839750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.